Swallowable metal microrobots that transform shape to deliver drugs and collect tissue samples before safely dissolving could ...

A new study from VIB and KU Leuven has revealed that Parkinson's disease comprises five distinct molecular subtypes, each requiring tailored therapeutic approaches.

Researchers at Tokyo University of Science have developed a safer synthetic route to β-heteroatom-substituted diazo esters, ...

Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...

Cryo-expansion microscopy has enabled researchers to visualise the three-dimensional organisation of cytotoxic T lymphocytes ...

Researchers have discovered that DNA wrapped around nucleosomes exists in multiple partially open states rather than simply ...

Researchers have developed a dual-mechanism compound that significantly extended survival in preclinical pancreatic cancer ...

Drug Target Review has launched an updated website to improve access to content across early-stage drug discovery, alongside ...

Researchers at the University of Houston have identified epithelial stress signalling as a key driver of Crohn's disease and ...

For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...

Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

VIB-VUB researchers have developed a patient-relevant lung adenocarcinoma model combined with SEPARATE-Seq technology to ...